Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Go back to Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.66 -7.42 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1157.08 | 52 Week High | $88.16 | |||
| Open | $1155.00 | 52 Week Low | $67.88 | |||
| Day High | $1158.72 | P/E | 266.13 | |||
| Day Low | $1141.50 | EPS | $4.32 | |||
| Volume | 516,367 | |||||

